Effect of Interferon beta-1-b on COVID-19 patients

Phase 2

• Conditions: Covid 19.; Covid 19 , Virus Identified; U07.1

• Registration Number: IRCT20201001048894N1
• Lead Sponsor: Bandare-abbas University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 January 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Positive result of Real time PCR
CT severity scoring
P o2 < 93mmHg
Respiratory rate more than 30 time per minute.

Exclusion Criteria

Diabetes
Cardiac diseases
pregnancy
Malignancy
Consumption of corticosteroids

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CT severiity score. Timepoint: At the beginning and the end of study. Method of measurement: By CT scan.;ABG - Pao2. Timepoint: At the beginning and at the end of study. Method of measurement: ABG assay system.;D-dimer that is fibrin degradation product (FDP). Timepoint: At the beginning and at the end of study. Method of measurement: By ELISA.